Improving testicular cancer pharmacotherapy through the use of pharmacogenomic approaches
0.3/100,000 inhabitants. It represents 1% of male neoplasms and 5% of urological tumors, with 3-10 new cases occurring per 100,000 males/per year. The most common subtypes of TCa are seminom and non-seminoma germ cell. Seminoma TCa represents about 30% t
| Author: | |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2014 |
| Country: | Chile |
| Language: | English |
| OAI Identifier: | oai:repositorio.anid.cl:10533/228658 |
| Online Access: | https://hdl.handle.net/10533/228658 |
| Access Level: | Open access |
| Summary: | 0.3/100,000 inhabitants. It represents 1% of male neoplasms and 5% of urological tumors, with 3-10 new cases occurring per 100,000 males/per year. The most common subtypes of TCa are seminom and non-seminoma germ cell. Seminoma TCa represents about 30% t |
|---|